Status: current, Defined. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2116351000168115 | Bordetella pertussis filamentous haemagglutinin antigen + Bordetella pertussis toxoid + diphtheria toxoid + Haemophilus influenzae serotype b conjugate (polyribosylribitol phosphate to tetanus toxoid) antigen + hepatitis B surface antigen + poliovirus serotype 1 inactivated antigen + poliovirus serotype 2 inactivated antigen + poliovirus serotype 3 inactivated antigen + tetanus toxoid (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2116361000168118 | diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2116471000168117 | diphtheria toxoid + tetanus toxoid + Bordetella pertussis toxoid + Bordetella pertussis filamentous haemagglutinin antigen + hepatitis B surface antigen + poliovirus type 1 inactivated antigen + poliovirus type 2 inactivated antigen + poliovirus type 3 inactivated antigen + Haemophilus influenzae type b conjugate (PRP-T) antigen | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2116481000168119 | DTPa-hepB-IPV-Hib (diphtheria + tetanus + pertussis + hepatitis B + inactivated poliomyelitis + Haemophilus influenzae type b conjugate (PRP-T)) vaccine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | Is a | diphtheria + tetanus vaccine | true | Inferred relationship | Some | ||
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | Is a | hepatitis B vaccine | true | Inferred relationship | Some | ||
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | Is a | Haemophilus influenzae type b conjugate (PRP-T) vaccine | true | Inferred relationship | Some | ||
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | Is a | polio trivalent inactivated vaccine | true | Inferred relationship | Some | ||
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | diphtheria toxoid | true | Inferred relationship | Some | 7 | |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | tetanus toxoid | true | Inferred relationship | Some | 5 | |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | hepatitis B surface antigen | true | Inferred relationship | Some | 9 | |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | Haemophilus influenzae type b conjugate (PRP-T) antigen | true | Inferred relationship | Some | 8 | |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | Bordetella pertussis toxoid | true | Inferred relationship | Some | 6 | |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | Bordetella pertussis filamentous haemagglutinin antigen | true | Inferred relationship | Some | 1 | |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | poliovirus type 1 inactivated antigen | true | Inferred relationship | Some | 2 | |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | poliovirus type 2 inactivated antigen | true | Inferred relationship | Some | 3 | |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | has intended active ingredient | poliovirus type 3 inactivated antigen | true | Inferred relationship | Some | 4 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine injection, 0.5 mL syringe | Is a | True | diphtheria + tetanus + pertussis + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-T) vaccine | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR